DIAGNOS INC (ADK.CA) Stock Price & Overview
TSX-V:ADK • CA2524423068
The current stock price of ADK.CA is 0.31 CAD. Today ADK.CA is up by 1.64%. In the past month the price increased by 6.9%. In the past year, price decreased by -1.59%.
ADK.CA Key Statistics
- Market Cap
- 37.327M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.05
- Dividend Yield
- N/A
ADK.CA Stock Performance
ADK.CA Stock Chart
ADK.CA Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to ADK.CA. When comparing the yearly performance of all stocks, ADK.CA is a bad performer in the overall market: 82.5% of all stocks are doing better.
ADK.CA Earnings
ADK.CA Forecast & Estimates
ADK.CA Groups
Sector & Classification
ADK.CA Financial Highlights
Over the last trailing twelve months ADK.CA reported a non-GAAP Earnings per Share(EPS) of -0.05. The EPS decreased by -10.34% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -406.07% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ADK.CA Ownership
ADK.CA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| VHI | VITALHUB CORP | 33.52 | 529.867M | ||
| NURS | HYDREIGHT TECHNOLOGIES INC | 8.88 | 143.592M | ||
| AIAI | NETRAMARK HOLDINGS INC | N/A | 84.484M | ||
| KDA | KDA GROUP INC | N/A | 26.007M | ||
| AVCR | AVRICORE HEALTH INC | N/A | 7.09M | ||
| KOVO | KOVO+ HOLDINGS INC | N/A | 4.422M | ||
| EKG | CARDIOCOMM SOLUTIONS INC | N/A | 1.976M |
Related stock screener links
View all stocks in the Health Care Technology Industry | View all stocks in the Health Care Sector | View all stocks on the TSX Venture Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
About ADK.CA
Company Profile
Diagnos, Inc. engages in the provision of healthcare technical services through the use of artificial intelligence (AI). The company is headquartered in Brossard, Quebec. The company went IPO on 2000-09-27. The company markets Computer Assisted Retinal Analysis (CARA), a software platform which assists health specialists in the detection of certain retinopathy pathologies through the computerized analysis of retina images. CARA is an in-house-hosted Web-based application that integrates fundus cameras with an image processing engine over a secure Internet connection. The CARA suite of applications allows an eye care specialist to more clearly visualize both normal retinal landmarks (optic nerve, vascular system, macula, fovea), and pathological changes (exudates, haemorrhages, micro-aneurisms, neo-vascularization). CARA is indicated for use by healthcare professionals in an adult general population in the context of a general eye-health exam.
Company Info
DIAGNOS INC
7005 Taschereau Blvd Suite 340
Brossard QUEBEC J4Z 1A7 CA
CEO: Andre Larente
Employees: 16
Phone: 14506788882
DIAGNOS INC / ADK.CA FAQ
Can you describe the business of DIAGNOS INC?
Diagnos, Inc. engages in the provision of healthcare technical services through the use of artificial intelligence (AI). The company is headquartered in Brossard, Quebec. The company went IPO on 2000-09-27. The company markets Computer Assisted Retinal Analysis (CARA), a software platform which assists health specialists in the detection of certain retinopathy pathologies through the computerized analysis of retina images. CARA is an in-house-hosted Web-based application that integrates fundus cameras with an image processing engine over a secure Internet connection. The CARA suite of applications allows an eye care specialist to more clearly visualize both normal retinal landmarks (optic nerve, vascular system, macula, fovea), and pathological changes (exudates, haemorrhages, micro-aneurisms, neo-vascularization). CARA is indicated for use by healthcare professionals in an adult general population in the context of a general eye-health exam.
What is the stock price of DIAGNOS INC today?
The current stock price of ADK.CA is 0.31 CAD. The price increased by 1.64% in the last trading session.
Does ADK stock pay dividends?
ADK.CA does not pay a dividend.
What is the ChartMill rating of DIAGNOS INC stock?
ADK.CA has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
Can you provide the sector and industry classification for DIAGNOS INC?
DIAGNOS INC (ADK.CA) operates in the Health Care sector and the Health Care Technology industry.